Loss of WHSC1 impairs MHC-I expression, weakens immune responses, and facilitates tumor progression, highlighting WHSC1 as a key mediator linking epigenetic modification to antigen presentation and immune checkpoint efficacy in CRC. This evidence concerns the gene NSD2 and colorectal carcinoma.